Results 21 to 30 of about 1,188 (177)

Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction

International Journal of COPD, 2014
Yoshiaki Kitaguchi,1,2 Keisaku Fujimoto,3 Masayuki Hanaoka,1 Takayuki Honda,4 Junichi Hotta,2 Jiro Hirayama2 1First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, 2Department of Internal Medicine, Okaya City Hospital ...
Kitaguchi Y, Fujimoto K, Hanaoka M, Honda T, Hotta J, Hirayama J   +5 more
doaj   +1 more source

Rheumatoid arthritis presenting by combined pulmonary fibrosis and emphysema with clubbing and pulmonary hypertension: A rare case report

Clinical Case Reports
Key Clinical Message A 60‐year‐old male smoker came with dyspnea. A rare condition known as combined pulmonary fibrosis and emphysema (CPFE) was observed on a chest CT scan.
Reza Basiri, Javad Davoodian, Amir Baniasad   +2 more
doaj   +2 more sources

Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer

International Journal of COPD, 2016
Atsushi Hata,1,2 Yasuo Sekine,1 Ohashi Kota,1 Eitetsu Koh,1 Ichiro Yoshino2 1Department of Thoracic Surgery, Tokyo Women’s Medical University Yachiyo Medical Centre, Yachiyo, 2Department of General Thoracic Surgery, Graduate School of Medicine ...
Hata A, Sekine Y, Kota O, Koh E, Yoshino I   +4 more
doaj   +1 more source

Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis [PDF]

RMD Open, 2019
Objectives This multicentre study aimed to investigate the overall mortality of combined pulmonary fibrosis and emphysema (CPFE) in systemic sclerosis (SSc) and to compare CPFE-SSc characteristics with those of other SSc subtypes (with interstitial lung ...
Carlo Alberto Scirè, Alarico Ariani, Mario Silva, Elena Bravi, Simone Parisi, Marta Saracco, Fabio De Gennaro, Cristian Caimmi, Francesco Girelli, Maria De Santis, Alessandro Volpe, Federica Lumetti, Vanessa Hax, Markus Bredemeier, Veronica Alfieri, Daniele Santilli, Flavio Cesare Bodini, Gianluca Lucchini, Flavio Mozzani, Valeria Seletti, Emanuele Bacchini, Eugenio Arrigoni, Dilia Giuggioli, Rafael Chakr, Luca Idolazzi, Giuseppina Bertorelli, Davide Imberti, Emanuele Michieletti, Giuseppe Paolazzi, Enrico Fusaro, Alfredo Antonio Chetta, Nicola Sverzellati   +31 more
doaj   +2 more sources

Attenuation Levels of Lung Fields in Quantitative Computed Tomography Evaluation Are Associated With Overall Survival and the Incidence of Acute Exacerbation in Combined Pulmonary Fibrosis and Emphysema: A Single-Center Retrospective Observational Study. [PDF]

Health Sci Rep
ABSTRACT Background and Aims Combined pulmonary fibrosis and emphysema (CPFE) is characterized by the coexistence of emphysematous lesions and fibrotic interstitial lung disease. We assessed the relationships of quantitative computed tomography (CT)‐derived measures with clinical characteristics and outcomes in CPFE.
Suzuki Y, Kitaguchi Y, Kinjo T, Goto N, Komatsu M, Ueno F, Wada Y, Ushiki A, Yasuo M, Fukushima K, Hanaoka M.   +10 more
europepmc   +2 more sources

The Dual Threat Combined Pulmonary Fibrosis and Emphysema (CPFE): Two Cases. [PDF]

Int J Chron Obstruct Pulmon Dis
Emphysema is common in fibrotic interstitial lung diseases, and its combination with pulmonary fibrosis is known as "Combined Pulmonary Fibrosis and Emphysema (CPFE) syndrome". The diagnosis of CPFE significantly impacts treatment strategies and prognosis. In this article, we report the clinical, imaging, and especially the pathological features of two
Peng S, Meng F, Wu C, Cao M, Li W, Xin X, Feng A.   +6 more
europepmc   +5 more sources

Effects of Antifibrotic Therapy in Patients with Combined Pulmonary Fibrosis and Emphysema: A US-Based Cohort Study [PDF]

Biomedicines
Background/Objectives: Combined pulmonary fibrosis and emphysema (CPFE) is associated with poor outcomes. We investigated the association of antifibrotic therapy on patients with CPFE. Methods: This retrospective study included adult patients, older than
Abhishek Shah, Esteban Kosak Lopez, Andrew Geller, Maanav Patel, Sadia Benzaquen   +4 more
doaj   +2 more sources

The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. [PDF]

Sci Rep, 2020
AbstractThe dominant pathogenesis underlying the combined pulmonary fibrosis and emphysema (CPFE) remains unresolved. The receptor for advanced glycation end-products (RAGE) is highly expressed in lung tissues and interacts with distinct multiple ligands, implicating it in certain lung diseases. To elucidate the pathogenesis of CPFE, we genotyped three
Kinjo T, Kitaguchi Y, Droma Y, Yasuo M, Wada Y, Ueno F, Ota M, Hanaoka M.   +7 more
europepmc   +4 more sources

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease [PDF]

Tuberculosis and Respiratory Diseases, 2022
Although chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) have distinct clinical features, both diseases may coexist in a patient because they share similar risk factors such as smoking, male sex, and old age.
Joon Young Choi, Jin Woo Song, Chin Kook Rhee   +2 more
doaj   +1 more source

Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition

Biomedicines, 2023
Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome characterized by upper lobe emphysema and lower lobe fibrosis manifested by exercise hypoxemia, normal lung volumes, and severe reduction of diffusion capacity of carbon monoxide. It
Diana Calaras, Alexander G. Mathioudakis, Zsofia Lazar, Alexandru Corlateanu   +3 more
doaj   +1 more source